The effects of regular aerobic exercise on renal functions in streptozotocin induced diabetic rats

Kurdak, Hatice; Sandikçi, Sunay; Ergen, Nilay; Dogan, Ayse; Kurdak, Sanli Sadi
June 2010
Journal of Sports Science & Medicine;Jun2010, Vol. 9 Issue 2, p294
Academic Journal
Diabetic nephropathy is a feared complication of diabetes since it can lead to end-stage renal failure and also it is a risk factor of cardiovascular disease. The important clinical problems caused by diabetic nephropathy are proteinuria and decreased renal function. Exercise is a cornerstone of diabetes management, along with diet and medication. Since acute exercise causes proteinuria and decreases glomerular filtration rate, the effect of exercise on diabetic nephropathy is controversial. The aim of this study was to investigate the effect of regular aerobic exercise on microalbuminuria and glomerular filtration rate in diabetic rats. Moderate diabetes was induced by streptozotocin (45 mg/kg IV) in rats and an aerobic exercise-training program on a treadmill was carried out for 8 weeks. Four groups of rats; control sedentary (CS), control exercise (CE), diabetic sedentary (DS) and diabetic exercise (DE) were included in the study. Blood glucose levels were determined from the plasma samples taken at the end of 4 weeks of stabilization period and 8 weeks of training program. Creatinine clearance (CCr) and microalbuminuria (MA) levels were determined to evaluate renal functions. The analyzed data revealed that regular aerobic exercise: 1) significantly decreased the plasma glucose level of the DE group compared to the DS group (p < 0.05), 2) significantly decreased the microalbuminuria level of the DE group compared to those of DS group (p < 0.01), 3) significantly decreased the creatinine clearance levels of the DE and CE groups compared to those of CS group (p < 0.05). The results of this study suggest that despite of decreasing creatinine clearance, regular submaximal aerobic exercise has a preventive effect on development of microalbuminuria and thus may retard nephropathy in diabetic rats.


Related Articles

  • Bone Marrow-Derived Mononuclear Cells Promote Improvement in Glomerular Function in Rats with Early Diabetic Nephropathy. Castiglione, Raquel C.; Maron-Gutierrez, Tatiana; Barbosa, Carolina M.L.; Ornellas, Felipe M.; Barreira, andré Luis; diBarros, Carolina B.a.; Vasconcelos-dos-Santos, andréia; Paredes, Bruno Diaz; Pascarelli, Bernardo M.; Diaz, Bruno L.; Rossi-Bergmann, Bartira; Takiya, Christina M.; Rocco, Patricia R.M.; Souza-Menezes, Jackson; Morales, Marcelo M. // Cellular Physiology & Biochemistry (Karger AG);Sep2013, Vol. 32 Issue 3, p699 

    Background/Aims: Diabetic nephropathy is one of the main causes of end-stage renal disease. The present study investigated the effect of mononuclear cell (MC) therapy in rats subjected to diabetic nephropathy. Methods: Male Wistar rats were divided into control (CTRL), diabetic (DM), CTRL+MC and...

  • A pilot randomized controlled trial of renal protection with pioglitazone in diabetic nephropathy. Agarwal, Rajiv; Saha, Chandan; Battiwala, Meher; Vasavada, Nina; Curley, Timothy; Chase, Shawn D.; Sachs, Nadine; Semret, Merfake H. // Kidney International;Jul2005, Vol. 68 Issue 1, p285 

    A pilot randomized controlled trial of renal protection with pioglitazone in diabetic nephropathy. Background. Diabetic nephropathy progresses relentlessly to end-stage renal disease (ESRD). Animal experiments have found that peroxisome proliferator activated receptor-γ...

  • mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. Inoki, Ken; Mori, Hiroyuki; Junying Wang; Suzuki, Tsukasa; SungKi Hong; Sei Yoshida; Blattner, Simone M.; Ikenoue, Tsuneo; Rüegg, Markus A.; Hall, Michael N.; Kwiatkowski, David J.; Rastaldi, Maria P.; Huber, Tobias B.; Kretzler, Matthias; Holzman, Lawrence B.; Wiggins, Roger C.; Kun-Liang Guan; Wang, Junying; Hong, SungKi; Yoshida, Sei // Journal of Clinical Investigation;Jun2011, Vol. 121 Issue 6, p2181 

    Diabetic nephropathy (DN) is among the most lethal complications that occur in type 1 and type 2 diabetics. Podocyte dysfunction is postulated to be a critical event associated with proteinuria and glomerulosclerosis in glomerular diseases including DN. However, molecular mechanisms of podocyte...

  • Improved Survival and Renal Prognosis of Patients With Type 2 Diabetes and Nephropathy With Improved Control of Risk Factors. Andrésdóttir, Gudbjörg; Jensen, Majken L.; Carstensen, Bendix; Parving, Hans-Henrik; Rossing, Kasper; Hansen, Tine W.; Rossing, Peter // Diabetes Care;Jun2014, Vol. 37 Issue 6, p1660 

    OBJECTIVE To evaluate long-term survival, development of renal end points, and decline in glomerular ltration rate (GFR) in patients with type 2 diabetes and diabetic nephropathy (DN) after renin-angiotensin system (RAS) inhibition and multifactorial treatment of cardiovascular risk factors have...

  • Relationship between Intra-renal Arterial Resistance Index (RI) and Albuminuria in Diabetic Patients. Fallah, Mahmoud; Nafisi-Moghadam, Reza; Nouri, Nader // Iranian Journal of Diabetes & Obesity (IJDO);Apr2012, Vol. 4 Issue 1, p7 

    OBJECTIVE: Diabetic nephropathy is a major diabetes complication. Arterial resistance index (RI) may predict deterioration in kidney function. This study was designed to compare renal arterial RI in different stages of renal function according to glomerular filtration rate (GFR), serum...

  • Risk factor profiles based on estimated glomerular filtration rate and dipstick proteinuria among participants of the Specific Health Check and Guidance System in Japan 2008. Iseki, Kunitoshi; Asahi, Koichi; Moriyama, Toshiki; Yamagata, Kunihiro; Tsuruya, Kazuhiko; Yoshida, Hideaki; Fujimoto, Shoichi; Konta, Tsuneo; Kurahashi, Issei; Ohashi, Yasuo; Watanabe, Tsuyoshi // Clinical & Experimental Nephrology;Apr2012, Vol. 16 Issue 2, p244 

    Background: Estimated glomerular filtration rate (eGFR) and albuminuria (proteinuria) are both important determinants of the risk of cardiovascular disease (CVD), end-stage renal disease (ESRD), and mortality. Few studies, however, have examined the risk factor profiles based on eGFR and...

  • Causes and consequences of lipoprotein(a) abnormalities in kidney disease. Kronenberg, Florian // Clinical & Experimental Nephrology;Apr2014, Vol. 18 Issue 2, p234 

    Lipoprotein(a) is one of the strongest genetically determined risk factors for cardiovascular disease, and patients with chronic kidney disease have major disturbances in lipoprotein(a) metabolism. Concentrations are increased and are influenced by glomerular filtration rate (GFR) and the amount...

  • Development of a Novel Polyclonal Antibody-Based Immunoassay for the Quantitation of Non-Albumin Urinary Proteins. Haigh, Wallace B.; Guralski, Donna M.; Arrigo, Lisa M.; Letsinger, Jack T.; Clarke, Michele; MacIsaac, Richard J.; Jerums, George; Very, Donald L. // Open Clinical Chemistry Journal;2013, Vol. 6, p1 

    Background: Better diagnostic methods to detect urinary proteinuria or albuminuria, important indicators of diabetic kidney disease, are needed. Here, we describe the development and performance qualification of a new immunoassay for the quantitation of non-albumin urinary proteins of 20 to 90...

  • Why is proteinuria such an important risk factor for progression in clinical trials? Jerums, George; Panagiotopoulos, Sianna; Isalamandris, Con; Allen, Terri J.; Gilbert, Richard E.; Comper, Wayne D. // Kidney International Supplement;Dec1997, Issue 63, pS87 

    There are strong reasons to justify the concept that proteinuria is a major risk factor for progression in clinical trials. The evidence is strongest where therapeutic intervention has been focused on established renal disease, when changes in albumin excretion rate (AER) and glomerular...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics